Thursday, October 29, 2020
Home Life Style Health & Fitness Research Finds That Drug Can Curb Dementia’s Delusions

Research Finds That Drug Can Curb Dementia’s Delusions

About 8 million Americans have dementia, and studies suggest that up to 30% of them develop psychosis.

A drug that curbs delusions in Parkinson’s patients did the same for people with Alzheimer’s disease and other forms of dementia in a study that was stopped early because the benefit seemed clear.

If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer’s in nearly two decades. It targets some of the most troubling symptoms that patients and caregivers face — hallucinations that often lead to anxiety, aggression, and physical and verbal abuse.

Results were disclosed Wednesday at a conference in San Diego.

Unmet need for treatment

“This would be a very important advance,” said one independent expert, Dr. Howard Fillit, chief science officer of the Alzheimer’s Drug Discovery Foundation.

Although the field is focused on finding a cure for dementia and preventing future cases, “there is a huge unmet need for better treatment” for those who have it now, said Maria Carrillo, the Alzheimer’s Association’s chief science officer.

The drug is pimavanserin, a daily pill sold as Nuplazid by Acadia Pharmaceuticals Inc. It was approved for Parkinson’s-related psychosis in 2016 and is thought to work by blocking a brain chemical that seems to spur delusions.

Dementia Drugs
Dementia is a syndrome in which there is deterioration in memory, thinking, behaviour and the ability to perform everyday activities. Pixabay

About 8 million Americans have dementia, and studies suggest that up to 30% of them develop psychosis.

“It’s terrifying,” said Dr. Jeffrey Cummings of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas. “You believe that people might be trying to hurt you. You believe that people are stealing from you. You believe that your spouse is unfaithful to you. Those are the three most common false beliefs.”

How the study worked

He consults for Acadia and helped lead the study, which included about 400 people with dementia and psychosis. All were given a low dose of the drug for three months, and those who seemed to respond or benefit were then split into two groups. Half continued on the drug and the others were given dummy pills for six months or until they had a relapse or worsening of symptoms. Neither the patients nor their doctors knew who was getting what.

Independent monitors stopped the study when they saw that those on dummy pills were more than twice as likely as those on the drug to relapse or worsen — 28% versus nearly 13%.

There were relatively few serious side effects — 5% in the drug group and 4% in the others. Headaches and urinary tract infections were more common among those on the drug. Two deaths occurred, but study leaders said neither was related to the drug.

The drug could become the first treatment for dementia
The drug could become the first treatment specifically for dementia-related psychosis. Pixabay

Carrillo said the study was small, but the drug’s effect seemed large, and it’s not known whether the federal Food and Drug Administration would want more evidence to approve a new use.

Risk of death

Current anti-psychotic medicines have some major drawbacks and are not approved for dementia patients.

“They’re often used off label because we have very few other options,” Fillit said.

ALSO READ: Researchers Associate Social Media Use to Eating Disorder in Adolescents

All carry warnings that they can raise the risk of death in elderly patients, as does Nuplazid.

Cost could be an issue — about $3,000 a month. What patients pay can vary depending on insurance coverage. (VOA)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,780FollowersFollow

Most Popular

Delayed Treatment of Brain Stroke Leads to Disabilities

Time is brain when it comes to the treatment of acute ischemic stroke. For every minute of delay in seeking treatment for a stroke,...

Foods that Reduce the Risks of Breast Cancer

A healthy lifestyle which includes exercise and a nutrient-dense diet may help reduce the risk of cancer. Foods that are rich in antioxidants and...

Delightful Golden Hues of Autumn in Switzerland

As beautiful as Switzerland is in summer, the changing colors of autumn paint the vistas of the country in delightful golden hues. Witnessing the...

Here’s How to Have a Better Digestive Health for Children

Has your toddler been refusing to poop in the toilet? Does he/she cry or make faces while passing stool or has the frequency of...

COVID Antibodies Respond at least for 5 Months, says Study

While some reports have come out saying antibodies to coronavirus go away quickly, a new study has revealed that the vast majority of individuals...

Twitter Rolls Out ‘Topics Feature’ In India

Twitter on Thursday rolled out a new feature called Topics in India in both English and Hindi that will make it easy for people...

Scientists Develop Smartwatch App for Deaf People

Scientists, including one of Indian-origin, have developed 'SoundWatch', a smartwatch app for the deaf and hard-of-hearing people who want to be aware of nearby...

Survey Reveals Power Quality Must Be Improved in India

Power distribution companies in India have to improve the power quality in the country, shows a survey. A joint study by Smart Power India (SPI),...

Recent Comments